ArticleJournal of materials science. Materials in medicine2026
Preparation and application of modified peach gum polysaccharide in the repair of central nervous system injury.
Article in Journal of materials science. Materials in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Spinal cord injury (SCI) is an irreversible neurological injury that leads to severe motor dysfunction and neurological deficiencies, imposing a large social load. Due to the difficulty of the SCI procedure, the prognosis is normally bad. In recent years, naturally derived hydrogels have garnered increasing attention. Peach gum (PG) primarily consists of macromolecular polysaccharides with abundant hydroxyl and carboxyl groups on its branched chains, making it amenable to modification. This study is the first to prepare carboxymethylated peach gum polysaccharide (CPG) using PG as the raw material and load it with nerve growth factor (NGF) to improve the adverse microenvironment post-SCI and promote axonal regeneration. Carboxymethylation modification of PG was done, and its effective change was verified by infrared spectroscopy and degree of replacement measurements. After loading NGF, its characterization was examined. The mechanical characteristics, thermal behavior, and self-healing ability of CPG + NGF were shown to be outstanding in the results. Cell experiments demonstrated that, compared to the sham-operated group, CPG + NGF significantly promotes neurite outgrowth and development in PC-12 cells. Ultimately, CPG + NGF was implanted into the injured spinal cords of rats, and research demonstrated that CPG + NGF significantly improves the microenvironment of the affected areas, fosters axonal regeneration in severely damaged spinal cord regions, and enhances motor function in the rats. The modified PG biopolymer scaffold developed in this study exhibits superior mechanical strength, excellent cytocompatibility, and enhanced biological functionality. In summary, this research provides new insights into the application of biomacromolecules in SCI repair.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.